Warfarin and ropinirole interaction

Annals of Pharmacotherapy

Volumn 35, Issue 10, 2001, Pages 1202-1204

  Bair, J D ^a   Oppelt, T F ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Parkinson's disease; Ropinirole; Warfarin

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CIPROFLOXACIN; ENOXACIN; ESTROGEN DERIVATIVE; HALOPERIDOL; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; ROPINIROLE; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING; CASE REPORT; DOSE RESPONSE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; INTERNATIONAL STANDARD UNIT; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0034793539     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10364     Document Type: Article

References (12)

1. Treatment of Parkinson's disease
2. The changing standard of care in Parkinson's disease: Current concepts and controversies
3. In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole
4. A comparison of the isomers of warfarin
5. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers
6. A method for estimating the probability of adverse drug reactions
7. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen
8. Potentiation of warfarin anticoagulation by sulfisoxazole
9. Phenylbutazone-warfarin interaction in man: Further stereochemical and metabolic considerations
10. Comment: TMP/SMX-warfarin interaction